Top Markets
#1 COTI COTI +40.13%
#2 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +32.72%
#3 Bitcoin Cash Bitcoin Cash +31.68%
#4 Fabric Protocol Fabric Protocol +31.09%
#5 GALA GALA +28.74%
#6 Tutorial Tutorial +27.35%
#7 Talus Network Talus Network +26.03%
#8 Magma Finance Magma Finance +24.61%
#9 Zora Zora +23.81%
#10 Arowana Arowana +22.89%
Coin of the day
COTI COTI
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Clasificación en acciones #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Precio por acción
$0.78611575
Capitalización bursátil
$60.45M
Cambio (1 día)
0.00%
Cambio (1 año)
-12.06%
País
NO
Comercio Lytix Biopharma AS (LYTIX)

Categoría

Healthcare
Ganancias de Lytix Biopharma AS (LYTIX)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Lytix Biopharma AS, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Lytix Biopharma AS desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH